US EditionPublished • loading... • Updated
Biotech enthusiasm still high as Revolution Medicines leads $1.5B stock offering wave
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Biotech enthusiasm still high as Revolution Medicines leads $1.5B stock offering wave
Revolution Medicines anchored Monday's offering surge, while Spyre Therapeutics and Allogene Therapeutics also joined in. The trio is planning to raise almost $1.5 billion through stock or debt sales as they look to fund further pipeline activity after positive data readouts from key programs.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
